Recent 13F filings as of September 2025 show that 272 institutional investors hold a position in Protagonist Therapeutics, Inc (NASDAQ:PTGX).
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 30 Sep, 2025 | 9,404,232 | -226,109 | -2.35% | $624,723,149.00 |
| FARALLON CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 6,196,006 | 24,000 | 0.39% | $411,600,679.00 |
| RTW INVESTMENTS, LP | 30 Sep, 2025 | 5,756,277 | 0 | 0.00% | $382,389,481.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 4,257,229 | -101,366 | -2.33% | $282,807,724.00 |
| STATE STREET CORP | 30 Sep, 2025 | 3,165,795 | -41,748 | -1.30% | $210,303,762.00 |
| BVF INC/IL | 30 Sep, 2025 | 2,560,916 | -650,125 | -20.25% | $170,121,650.00 |
| JOHNSON & JOHNSON | 30 Sep, 2025 | 2,449,183 | 0 | 0.00% | $162,699,227.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 30 Sep, 2025 | 1,908,446 | 870,708 | 83.90% | $126,778,068.00 |
| UBS Group AG | 30 Sep, 2025 | 1,896,008 | -605,243 | -24.20% | $125,951,812.00 |
| Deep Track Capital, LP | 30 Sep, 2025 | 1,715,691 | -1,530,208 | -47.14% | $113,973,353.00 |
| Woodline Partners LP | 30 Sep, 2025 | 1,438,247 | 491,363 | 51.89% | $95,542,748.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 30 Sep, 2025 | 1,416,646 | -27,584 | -1.91% | $94,122,036.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 30 Sep, 2025 | 1,220,436 | 283,733 | 30.29% | $81,075.00 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 1,139,854 | 382,144 | 50.43% | $75,720,501.00 |
| JANUS HENDERSON GROUP PLC | 30 Sep, 2025 | 1,100,821 | 653,993 | 146.36% | $73,165,449.00 |
| MARSHALL WACE, LLP | 30 Sep, 2025 | 1,085,564 | 1,065,848 | 5,406.01% | $72,114,017.00 |
| PERCEPTIVE ADVISORS LLC | 30 Sep, 2025 | 1,030,134 | -44,314 | -4.12% | $68,431,802.00 |
| Commodore Capital LP | 30 Sep, 2025 | 1,025,000 | -50,000 | -4.65% | $68,090,750.00 |
| Invesco Ltd. | 30 Sep, 2025 | 1,003,706 | 282,026 | 39.08% | $66,676,188.00 |
| ADAR1 Capital Management, LLC | 30 Sep, 2025 | 989,182 | 41,113 | 4.34% | $65,711,360.00 |